Company Info
Phone(857) 264-4280
Year Established
2010
Ticker
RYTM
Exchange
NASDAQ
Contacts
David Meeker, MDChair, President & CEO
Elisabeth Cronert-Bendell
Senior VP, Head of Strategy
Hunter Smith
CFO
Jennifer Chien
Executive VP, Head of North America
Dana Washburn, M.D.
Senior VP, Clinical Development
Joe Shulman
CTO
Jim Flaherty
General Counsel
Alastair Garfield, Ph.D.
CSO
Company Description
Rhythm is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.
